10th Annual Summit World Bispecific

10th Annual Summit World Bispecific is organized by Hanson Wade and will be held from Sep 17 - 19, 2019 at The Westin Waltham Boston, Waltham, Massachusetts, United States of America.

Description:
World Bispecific is the Only End-to-End Meeting Dedicated Solely to Enhancing the Development of Bispecific Therapeutics

Focused completely on the development of bispecifics, the World Bispecific Summit represents a unique opportunity to engage with your peers to discuss strategies to overcome the key challenges holding back progress in the field.

Rather than presenting vague overviews of platforms, this meeting will delve directly into the technical and scientific insights that will enable you to advance your candidate therapeutic into the clinic as efficiently and cost-effectively as possible.

Challenges:
• Improve the Therapeutic Window in Solid Tumour Indications
• Enhance the Translatability & Predictability of Preclinical Approaches
• Learn Directly from Clinical Case StudiesPioneer Bispecifics in Oncology & Beyond
• Pioneer Bispecifics in Oncology & Beyond
• Optimize CMC & Analytical Strategies

Workshop A
9:00 – 12:00
Enhancing the Translatability of Immuno-Oncology Therapeutics
Description:
An unprecedented range of immuno-oncology combination approaches are currently under investigation, but without robust preclinical validation backing the mechanism of action of these strategies, many of these studies will fail to reach their clear potential. This interactive workshop will share how the efficacy of immuno-oncology agents can be investigated in translational culture systems, providing you with the valuable tools to enhance your immuno-oncology work.

Attend this workshop to gain valuable insights into:
• A novel ex vivo human system to investigate immuno-oncology agents
• A novel ex vivo human system to investigate immuno-oncology agents
• Insights into the mechanistic data that can be generated from translational systems and how this can enhance immuno-oncology clinical development

Workshop B
1:00 – 4:00
Innovative Discovery and Delivery Approaches for Bispecifics for Infectious Disease Indications
Developing bispecifics for infectious diseases is challenging, but the potential rewards for success are huge, given the global unmet need in many of these indications. An increasing amount of bispecific development is taking place outside oncology, using new enabling technologies to tackle the complex challenges inherent to infectious diseases applications is critical to success.

Attend this workshop to gain valuable insights into:
• Case studies outlining protein engineering innovations to develop and adapt formats to complex biological contexts
• Investigating new gene-encoded methods for in vivo delivery using non-viral synthetic DNA to enable to body to produce bispecifics
• Understanding the flexibility and range of different bispecific designs able to be delivered using this approach
• The future promise of bispecifics in addressing unmet medical need in the infectious disease space

Time: 9:00 am to 4:00 pm